corona COVID-19
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Voluntary participants with an age of 18 years or older. He or she must be able to read and understand the informed consent form and to independently perform a capillary blood collection. - At least 1 PCR confirmed SARS-CoV-2 infection OR a positive result in serology through venous blood collection
Exclusion criteria
Exclusion criteria: - Voluntary participants under 18 years old. - Absence of PCR confirmed SARS-CoV-2 infection OR patients with a confirmed respiratory infection with a pathogen other than SARS-CoV-2 OR patients with negative test result for SARS-CoV-2 serology in venous blood collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: * The clinically functional outcome measure of the Wantai serological tests on capillary blood (serum collected with the Ser-Col device) will be compared with the outcome measures of the Wantai® tests on the venous blood sample for the detection of total (combined IgM and IgG) antibodies against SARS-CoV-2. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: * The difference in sensitivity and specificity for the detection of total SARS-CoV-2 antibodies in saliva versus venous and capillary blood. * Quantitative differences in measured titers of total antibodies against SARS-CoV-2 using the Wantai® assay between the two blood collecting systems, and saliva using a micro-array. | — |
Countries
Netherlands